Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Regeneration of Damaged Muscle Tissue Depends on Cyclin-dependent Kinase 9

By Biotechdaily staff writers
Posted on 08 Jul 2008
Researchers studying how muscle tissue regenerates after damage caused by disease, injury, or aging have found that the protein encoded by the cdk9-55 gene plays a fundamental role in muscle regeneration and differentiation.

Healing of muscle tissue begins with the activation of satellite cells (myogenic stem cells). More...
The satellite cells abandon their normal quiescent state, proliferate with activation of MyoD and Myf-5 gene expression, and finally differentiate and fuse to reconstitute the injured muscle architecture. Previous studies had shown that cdk9 (cyclin-dependent kinase 9) was required to activate MyoD.

In the current work, which was published in the June 10, 2008, issue of the Journal of Cellular Physiology, investigators at Temple University (Philadelphia, PA, USA) found that cdk9-55, a variation of the cdk9 gene, was induced specifically when satellite cells began differentiation and was necessary for the genetic reprogramming required to complete the muscle tissue regeneration process.

Furthermore, cdk9-55 could be used to increase the cell mass in healthy muscle tissue.
"This discovery has important implications for tissue regeneration in muscle tissue damaged by disease and injury, genetic disorders such as muscular dystrophy, chronic disorders like cancer or HIV that may impair muscle regeneration, and diseases related to aging,” said senior author Dr. Antonio Giordano, professor of biology at Temple University.


Related Links:
Temple University

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.